SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-16-087569
Filing Date
2016-03-11
Accepted
2016-03-11 16:19:36
Documents
8
Period of Report
2016-04-07
Effectiveness Date
2016-03-11

Document Format Files

Seq Description Document Type Size
1 DEF 14A v433064_def14a.htm DEF 14A 600568
2 GRAPHIC v433064_pc-1a.jpg GRAPHIC 726408
3 GRAPHIC v433064_pc-2a.jpg GRAPHIC 706074
4 GRAPHIC line.gif GRAPHIC 43
5 GRAPHIC logo_ibio.jpg GRAPHIC 28267
6 GRAPHIC sig_elizabeth-moyle.jpg GRAPHIC 18971
7 GRAPHIC sig_robert-kay.jpg GRAPHIC 21466
8 GRAPHIC spacer.gif GRAPHIC 43
  Complete submission text file 0001144204-16-087569.txt   2669810
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-35023 | Film No.: 161500979
SIC: 2834 Pharmaceutical Preparations